Can I read Onychomycosis in Older Adults: Prevalence, Diagnosis, and Management on EtoBox?

Onychomycosis in Older Adults: Prevalence, Diagnosis, and Management by Aditya K. Gupta; Maanasa Venkataraman; Mesbah Talukder is a Medicine article available to read on EtoBox.

What is Onychomycosis in Older Adults: Prevalence, Diagnosis, and Management about?

The risk of having onychomycosis increases with age. Data suggest that the prevalence of onychomycosis may be ≥ 20% in subjects aged ≥ 60 years and ≥ 50% in those aged ≥ 70 years. Older males are 2.1 times more prone to onychomycosis than are females. Although most nail dystrophies (approximately 50%) are caused by onychomycosis, proper clinical assessment followed by mycological examination is recommended to exclude other conditions such as nail trauma, lichen planus, and psoriasis. The US FDA-approved onychomycosis treatments are systemic antifungals (terbinafine and itraconazole) for severe onychomycosis and topical antifungals (ciclopirox 8%, efinaconazole 10%, and tavaborole 5%) for mild-to-moderate onychomycosis. Oral fluconazole is used off-label, and itraconazole may be considered for non-dermatophyte onychomycosis. Recently, fosravuconazole was approved in Japan for onychomycosis treatment. Although the treatment options and durations are the same for older patients as for other age groups, a clinical decision should take into account various age-related factors such as comorbidities, polypharmacy, hepatic and renal insufficiency, and noncompliance. Clinicians should also

Who reads Onychomycosis in Older Adults: Prevalence, Diagnosis, and Management?

Author

Aditya K. Gupta; Maanasa Venkataraman; Mesbah Talukder

Publisher

Springer Science and Business Media LLC

Published

2022

Language

EN

Field

Medicine (Health Sciences)